应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
盘前交易 07-16 09:22:18 EDT
50.56
+1.49
+3.04%
盘前
50.77
+0.21
+0.42%
09:22 EDT
最高
51.00
最低
49.36
成交量
1,031万
今开
49.36
昨收
49.07
日振幅
3.34%
总市值
2,244亿
流通市值
1,612亿
总股本
44.39亿
成交额
5.20亿
换手率
0.32%
流通股本
31.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺和诺德口服减重药物获欧盟委员会批准
智通财经 · 15:01
诺和诺德口服减重药物获欧盟委员会批准
市场消息:诺和诺德Wegovy口服片获欧盟批准为首个口服GLP-1减肥药。
智通财经 · 07-15 23:51
市场消息:诺和诺德Wegovy口服片获欧盟批准为首个口服GLP-1减肥药。
异动解读|诺和诺德盘中上涨3.07%,口服减重药处方量以89%份额碾压礼来
行情直击 · 07-15 22:28
异动解读|诺和诺德盘中上涨3.07%,口服减重药处方量以89%份额碾压礼来
【券商聚焦】礼来口服减重药上市三月处方量大幅落后诺和诺德 机构下调Foundayo销售额预期
金吾财讯 · 07-15 21:50
【券商聚焦】礼来口服减重药上市三月处方量大幅落后诺和诺德 机构下调Foundayo销售额预期
减肥药大战:诺和诺德口服药遥遥领先礼来
智通财经 · 07-15 08:45
减肥药大战:诺和诺德口服药遥遥领先礼来
诺和诺德印度高管:产品将于下周推出。
智通财经 · 07-09
诺和诺德印度高管:产品将于下周推出。
诺和诺德中国称旗下糖尿病治疗创新药司美格鲁肽注射液等纳入新版国家基本药物目录。
智通财经 · 07-09
诺和诺德中国称旗下糖尿病治疗创新药司美格鲁肽注射液等纳入新版国家基本药物目录。
诺和诺德:从“销往中国”到“造福全球”
经济日报 · 07-09
诺和诺德:从“销往中国”到“造福全球”
诺和诺德CEO:将推进中国业务和全球战略深度整合
智通财经 · 07-08
诺和诺德CEO:将推进中国业务和全球战略深度整合
Vivani Medical 与 Novo Nordisk 达成协议,评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139
GlobeNewswire · 07-08
Vivani Medical 与 Novo Nordisk 达成协议,评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139
异动解读|诺和诺德盘中下跌3.05%,报48.70美元
行情直击 · 07-06
异动解读|诺和诺德盘中下跌3.05%,报48.70美元
汇丰将诺和诺德目标价从280丹麦克朗上调至300丹麦克朗。
智通财经 · 07-06
汇丰将诺和诺德目标价从280丹麦克朗上调至300丹麦克朗。
诺和诺德(NVO)涨3.8% 施压供应商争取折扣 削减成本反攻减肥药市场
金吾财讯 · 07-02
诺和诺德(NVO)涨3.8% 施压供应商争取折扣 削减成本反攻减肥药市场
异动解读|诺和诺德盘中上涨3.09%,Medicare覆盖落地叠加供应链降本举措提振
行情直击 · 07-02
异动解读|诺和诺德盘中上涨3.09%,Medicare覆盖落地叠加供应链降本举措提振
异动解读|诺和诺德盘中上涨3.18%,美国联邦医保首次覆盖减肥药利好兑现
行情直击 · 07-01
异动解读|诺和诺德盘中上涨3.18%,美国联邦医保首次覆盖减肥药利好兑现
诺和诺德:符合条件的联邦医疗保险参保患者现在可按月自付50美元购得Wegovy。
智通财经 · 07-01
诺和诺德:符合条件的联邦医疗保险参保患者现在可按月自付50美元购得Wegovy。
美国联邦医疗保险七月起首次覆盖减肥药物,诺和诺德股价应声上涨
环球市场播报 · 06-30
美国联邦医疗保险七月起首次覆盖减肥药物,诺和诺德股价应声上涨
杰富瑞将诺和诺德目标股价从270丹麦克朗上调至285丹麦克朗。
智通财经 · 06-30
杰富瑞将诺和诺德目标股价从270丹麦克朗上调至285丹麦克朗。
高盛将诺和诺德目标价从305丹麦克朗上调至310丹麦克朗。
智通财经 · 06-26
高盛将诺和诺德目标价从305丹麦克朗上调至310丹麦克朗。
诺和诺德(NVO.US)美国负责人表示Wegovy口服剂型销量中直接面向消费者的销售占比达90%注射剂型该比例为30%。
智通财经 · 06-25
诺和诺德(NVO.US)美国负责人表示Wegovy口服剂型销量中直接面向消费者的销售占比达90%注射剂型该比例为30%。
加载更多
公司概况
公司名称:
诺和诺德
所属市场:
NYSE
上市日期:
--
主营业务:
Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司,也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦,业务遍及约80个国家,产品销往约170个国家。
发行价格:
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":50.56,"timestamp":1784145600000,"preClose":49.07,"halted":0,"volume":10314858,"hourTrading":{"tag":"盘前","latestPrice":50.77,"preClose":50.56,"latestTime":"09:22 EDT","volume":219222,"amount":11186991.171684,"timestamp":1784208135744,"change":0.21,"changeRate":0.004153,"amplitude":0.019185},"delay":0,"changeRate":0.030364785001018992,"floatShares":3187922885,"shares":4439052849,"eps":4.228648,"marketStatus":"盘前交易","change":1.49,"latestTime":"07-16 09:22:18 EDT","open":49.36,"high":51,"low":49.36,"amount":520280127.53303397,"amplitude":0.033422,"askPrice":50.78,"askSize":500,"bidPrice":50.74,"bidSize":2660,"shortable":3,"etf":0,"ttmEps":4.228648,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784208600000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":50.56,"dividendRate":0.034057,"preHourTrading":{"tag":"盘前","latestPrice":50.77,"preClose":50.56,"latestTime":"09:22 EDT","volume":219222,"amount":11186991.171684,"timestamp":1784208135744,"change":0.21,"changeRate":0.004153,"amplitude":0.019185},"postHourTrading":{"tag":"盘后","latestPrice":50.6596,"preClose":50.56,"latestTime":"19:59 EDT","volume":154918,"amount":7827010.6038,"timestamp":1784159998958,"change":0.0996,"changeRate":0.00197,"amplitude":0.005324},"volumeRatio":1.4753143121075056,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1784260800000,"strike":"50.0","timestamp":1784137042951,"price":0.48,"volume":1600,"amount":76800,"type":"+"},{"symbol":"NVO","call":true,"expireDate":1787284800000,"strike":"52.5","timestamp":1784135400893,"price":2.16,"volume":1230,"amount":265680,"type":"+"}]},"impliedVol":0.5056,"impliedVolPercentile":0.5},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2651411341","title":"诺和诺德口服减重药物获欧盟委员会批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2651411341","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651411341?lang=zh_cn&edition=full","pubTime":"2026-07-16 15:01","pubTimestamp":1784185275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","IE00BZ1G4Q59.USD","BK4007","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","PPH","LU1093756168.USD","NVO","NVOX","BK4588","LU0154236417.USD","BK4599","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651629864","title":"市场消息:诺和诺德Wegovy口服片获欧盟批准为首个口服GLP-1减肥药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651629864","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651629864?lang=zh_cn&edition=full","pubTime":"2026-07-15 23:51","pubTimestamp":1784130670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU0154236417.USD","IE00BZ1G4Q59.USD","NVOH","BK4599","IE00BKVL7J92.USD","PPH","LU1093756168.USD","LU1093756325.SGD","BK4007","BK4532","NVO","BK4588","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125700765","title":"异动解读|诺和诺德盘中上涨3.07%,口服减重药处方量以89%份额碾压礼来","url":"https://stock-news.laohu8.com/highlight/detail?id=1125700765","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125700765?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:28","pubTimestamp":1784125728,"startTime":"0","endTime":"0","summary":"7月15日,诺和诺德盘中上涨3.07%,报50.57美元/股,成交额1.14亿美元。消息面上,IQVIA最新处方数据显示,截至7月3日当周,Wegovy口服制剂在美国的单周处方量约15.31万张,礼来Foundayo仅1.96万张,诺和诺德拿下口服减重药品类89%的处方量,礼来仅占11%。Wegovy口服制剂上市第13周单周处方量便突破10.5万张,规模为同期Foundayo的5倍以上,先发优势显著。机构随即下调礼来Foundayo销售额预期,进一步确认诺和诺德在口服减重赛道的领先地位。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"异动解读|诺和诺德盘中上涨3.07%,口服减重药处方量以89%份额碾压礼来","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651469666","title":"【券商聚焦】礼来口服减重药上市三月处方量大幅落后诺和诺德 机构下调Foundayo销售额预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2651469666","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651469666?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:50","pubTimestamp":1784123427,"startTime":"0","endTime":"0","summary":"IQVIA 截至 7 月 3 日当周数据显示,当期 Wegovy 口服制剂美国处方量约 15.31 万张,Foundayo 仅 1.96 万张,诺和诺德拿下该品类 89% 处方量,礼来占比仅 11%。诺和诺德年内先行推出口服司美格鲁肽 Wegovy,礼来 4 月推出 Foundayo。依托先发优势,Wegovy 口服制剂上市第 13 周单周处方量便超 10.5 万张,规模为同期 Foundayo 的 5 倍以上。礼来发言人表示,伴随医生、药房及患者认知提升,Foundayo 销售势能有望逐步释放。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302610","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRX11.SGD","LU2471134952.CNY","LU2750360997.AUD","LU0316494557.USD","BK4007","IE00B7KXQ091.USD","MEDX","IE00BFSS7M15.SGD","LU2324357040.USD","SG9999017495.SGD","IE00B2B36J28.USD","LU1035775433.USD","LU0353189763.USD","LU2237443978.SGD","LU0174119429.USD","LU2265009873.SGD","LU0320765992.SGD","LU0238689110.USD","LU1057294990.SGD","LU1989771016.USD","SGXZ99366536.SGD","LU0823434583.USD","LU1366192091.USD","LU2236285917.USD","LU0320765059.SGD","LU2471134796.USD","LU1069344957.HKD","LU2237443622.USD","LU2213496289.HKD","LU2168564065.EUR","LU2462591350.SGD","SG9999014914.USD","BK4534","LU0079474960.USD","SGXZ81514606.USD","LU1712237335.SGD","IE00BKPKM429.USD","JDOC","LU0106261372.USD","LU1551013342.USD","LU2756315664.SGD","LU2237443382.USD","LU0417517546.SGD","IE0002141913.USD","BK4532","LU2361045086.USD","SG9999015986.USD","BK4581","IE00B1XK9C88.USD","ILDR","LU2468319806.SGD","LU0820561909.HKD","IE00BKVL7J92.USD","LU2106854487.HKD","LU2456880835.USD","LU1323610961.USD","THNR","IE00B1BXHZ80.USD","LU0114720955.EUR","LU0964807845.USD","LU2552382058.USD","LU0820561818.USD","LU2089284900.SGD","IE00BWXC8680.SGD","LU2063271972.USD","LU2361044949.HKD","LU2491049909.HKD","LU0456855351.SGD","LU2461242641.AUD","LU2746668974.SGD","LU2360106947.USD","LU0820562030.AUD","IE0004445239.USD","LU2750360641.GBP","WDNA","LU0289739699.SGD","LU0154236417.USD","LU0354030511.USD","CANC","LU0210536198.USD","LLII","LU2471134879.HKD","LU0266013472.USD","BK4585","LU0672654240.SGD","LU1868836757.USD","LU0471298777.SGD","ELIL","SGXZ57979304.SGD","IE0009355771.USD","LU0203202063.USD","LU0708995401.HKD","LU0432979614.USD","LU2108987350.USD","LU0823416689.USD","LU1868837136.USD","LU1868837300.USD","LU1291159041.SGD","LU2552382215.SGD","SG9999014898.SGD","IE00BFSS8Q28.SGD","LU2552382132.HKD","FTXH","LU1804176565.USD","LU1629891620.HKD","LU1064131342.USD","LU0345770308.USD","LU2756315318.SGD","LU1814569148.SGD","VHT","RXL","LU2462157665.USD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0882574139.USD","LU0256863902.USD","LU0823434740.USD","LU2168564495.EUR","LU2361044865.SGD","SG9999018865.SGD","IE00B4JS1V06.HKD","PJP","LU0786609619.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","IXJ","LU1145028129.USD","LU2023251221.USD","LU2896262040.SGD","PPH","SG9999001176.SGD","LU1280957306.USD","IE00B4R5TH58.HKD","LU0225283273.USD","LU2087625088.SGD","LU0683600562.USD","LU2028103732.USD","LU0158827781.USD","LU0640476718.USD","IE0001KFT4U8.USD","LU1023059063.AUD","IYH","LU2023250330.USD","LU2168564222.USD","LU0354030438.USD","LU0006306889.USD","LU2211815571.USD","LU2237443465.HKD","LU2168564149.EUR","AGNG","LU1548497426.USD","NVOH","LU0058720904.USD","LLY","LU0122379950.USD","LU2491050154.USD","LU0096364046.USD","LU2271345857.HKD","CURE","SGXZ31699556.SGD","LU0158827948.USD","LU2237443549.SGD","LU0689472784.USD","LU2417539215.USD","LU0203201768.USD","GB00BDT5M118.USD","LU2111349929.HKD","IE0005OL40V9.USD","LU2168563687.JPY","LU2237443895.HKD","LU2471134523.USD","NVOX","BK4516","LU0234572021.USD","LU0889565916.HKD","LU1061106388.HKD","IE00BZ1G4Q59.USD","IE00BN29S564.USD","OZEM","LU2237438978.USD","LU1974910355.USD","LU1093756168.USD","BK4533","LU1127390331.HKD","LU2491050071.SGD","LU0094547139.USD","LU0943347566.SGD","SGXZ51526630.SGD","SG9999015945.SGD","BK4588","LU0345770993.USD","LU1093756325.SGD","LU1868836914.USD","LU0061475181.USD","LU1988902786.USD","LU2023250504.SGD","LU1983299246.USD","LU0385154629.USD","LU2112291526.USD","LU2357305700.SGD","LU0133085943.USD","LU0466842654.USD","LU2746668461.USD","SG9999014880.SGD","LU1623119135.USD","IE00BK4W5M84.HKD","LU1267930730.SGD","LU1868836591.USD","BK4599","GDOC","XLV","IE00B775H168.HKD","LU0882574055.USD","LU1551013425.SGD","SG9999015978.USD","SG9999001176.USD","IE00BKDWB100.SGD","IE00BJJMRY28.SGD","FHLC","IHE","LU2089283258.USD","LLYX","IE00BJJMRZ35.SGD","LU2089984988.USD","MEDI","LU0109394709.USD","LU2264538146.SGD","NVO","SG9999018857.SGD","LU0471298694.HKD","LU1232071149.USD","LU0097036916.USD","IE0004445015.USD","LU0109391861.USD","IE00BK4W5L77.USD","SG9999015952.SGD","LU0353189680.USD","LU0256863811.USD","LU2602419157.SGD","SG9999014906.USD","HRTS","LLYZ","LU1917777945.USD","SG9999013999.USD","LU0198837287.USD","LU0787776722.HKD","LU1720051017.SGD","ELIS","LU0323591593.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480626","title":"减肥药大战:诺和诺德口服药遥遥领先礼来","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651480626?lang=zh_cn&edition=full","pubTime":"2026-07-15 08:45","pubTimestamp":1784076344,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B1BXHZ80.USD","LU0289739699.SGD","LU0787776722.HKD","LLYZ","LU2237443978.SGD","LU0385154629.USD","LU0154236417.USD","LU0097036916.USD","LU1093756168.USD","LU2271345857.HKD","LU0094547139.USD","LU2750360641.GBP","LU2471134952.CNY","LU0432979614.USD","LU0198837287.USD","LU2108987350.USD","LU2361044949.HKD","LU1057294990.SGD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2756315318.SGD","LU1064131342.USD","LU1983299246.USD","HRTS","LU0210536198.USD","SGXZ31699556.SGD","LU0238689110.USD","BK4533","LU0158827781.USD","LU2089984988.USD","LU1712237335.SGD","LU0466842654.USD","LU2237443895.HKD","LU1323610961.USD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU2462157665.USD","LU0006306889.USD","LU2357305700.SGD","SG9999015978.USD","XLV","LU2089284900.SGD","LU2471134796.USD","LU2552382058.USD","LU2461242641.AUD","LU0266013472.USD","SGXZ57979304.SGD","LU0109391861.USD","LU2213496289.HKD","LU1551013425.SGD","LU0417517546.SGD","ELIS","LU1069344957.HKD","LU1868836591.USD","GDOC","LU0964807845.USD","LU1804176565.USD","LU2471134879.HKD","IE0004445239.USD","LU0106261372.USD","LU0203201768.USD","LU2168564065.EUR","LU2265009873.SGD","CANC","LU0061475181.USD","LU0823434740.USD","LU2023251221.USD","LU2236285917.USD","IE0001KFT4U8.USD","SGXZ51526630.SGD","LU2211815571.USD","LU0079474960.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU2237443465.HKD","LU2023250504.SGD","IE00B4JS1V06.HKD","LU0353189763.USD","LU1868837300.USD","LU0345770993.USD","SGXZ81514606.USD","JDOC","LU2750360997.AUD","LU0109394709.USD","IHE","LU1061106388.HKD","IE00BFSS7M15.SGD","LU2468319806.SGD","LU2361044865.SGD","SG9999015986.USD","LU0456855351.SGD","RXL","LU0689472784.USD","IE00BJJMRY28.SGD","LU1232071149.USD","SG9999013999.USD","LU0158827948.USD","LU2023250330.USD","IE00BJJMRX11.SGD","SG9999014914.USD","IE00B1XK9C88.USD","LU0256863902.USD","LU2237443622.USD","LLY","LLYX","LU1814569148.SGD","LU0203202063.USD","IE00BKPKM429.USD","LU0256863811.USD","LU2361045086.USD","BK4516","LU0122379950.USD","IE00BJLML261.HKD","LU1988902786.USD","LU2106854487.HKD","SGXZ99366536.SGD","LU0471298777.SGD","LU1868837136.USD","FTXH","IE00BZ1G4Q59.USD","LU0823434583.USD","LU0345770308.USD","LU0320765992.SGD","LU0820562030.AUD","LU1548497426.USD","BK4007","LU1035775433.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU1974910355.USD","AGNG","IE00B7KXQ091.USD","LU0058720904.USD","LU1917777945.USD","ELIL","IE0005OL40V9.USD","LU0225283273.USD","LU0354030511.USD","LU1127390331.HKD","LU1868836914.USD","LU2111349929.HKD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LLII","IE00B775H168.HKD","NVOH","SG9999017495.SGD","LU0672654240.SGD","LU0882574055.USD","LU1267930730.SGD","LU0353189680.USD","WDNA","LU0320765059.SGD","PPH","LU2324357040.USD","LU1280957306.USD","LU1551013342.USD","LU2168563687.JPY","IE00BKDWB100.SGD","LU0708995401.HKD","LU1093756325.SGD","LU0820561909.HKD","OZEM","LU0786609619.USD","LU0323591593.USD","LU2417539215.USD","LU2237443549.SGD","LU0943347566.SGD","LU2746668974.SGD","LU2746668461.USD","SG9999014898.SGD","BK4588","LU0471298694.HKD","LU0114720955.EUR","LU0234572021.USD","LU2491050154.USD","SG9999014906.USD","BK4585","SG9999001176.USD","LU0096364046.USD","LU1720051017.SGD","LU2491049909.HKD","LU1629891620.HKD","LU2087625088.SGD","LU2264538146.SGD","LU1023059063.AUD","NVO","NVOX","IE00BN29S564.USD","LU2360106947.USD","LU2602419157.SGD","LU0640476718.USD","LU0882574139.USD","LU2896262040.SGD","LU2456880835.USD","LU2112291526.USD","LU1720051108.HKD","LU1989771016.USD","LU1868836757.USD","LU2471134523.USD","LU2552382215.SGD","LU0133085943.USD","MEDX","SG9999018857.SGD","IE0004445015.USD","LU1623119135.USD","IE0009355771.USD","LU0316494557.USD","LU2063271972.USD","LU2168564222.USD","LU0683600562.USD","LU2168564149.EUR","LU0820561818.USD","BK4534","IXJ","IE00BWXC8680.SGD","LU2756315664.SGD","LU1366192091.USD","IE00B2B36J28.USD","LU0354030438.USD","SG9999014880.SGD","SG9999018865.SGD","LU1291159041.SGD","BK4581","BK4532","LU2237443382.USD","LU2028103732.USD","GB00BDT5M118.USD","LU2552382132.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","SG9999015952.SGD","LU2089283258.USD","IE00BFSS8Q28.SGD","IE00B4R5TH58.HKD","LU2237438978.USD","VHT","ILDR","SG9999001176.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650994978","title":"诺和诺德印度高管:产品将于下周推出。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650994978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650994978?lang=zh_cn&edition=full","pubTime":"2026-07-09 14:50","pubTimestamp":1783579852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","BK4585","IE00BZ1G4Q59.USD","BK4588","NVO","NVOX","THNR","NVOH","BK4599","LU0154236417.USD","LU1093756325.SGD","PPH","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650194633","title":"诺和诺德中国称旗下糖尿病治疗创新药司美格鲁肽注射液等纳入新版国家基本药物目录。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650194633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650194633?lang=zh_cn&edition=full","pubTime":"2026-07-09 13:48","pubTimestamp":1783576102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756325.SGD","NVOX","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","PPH","OZEM","BK4599","BK4588","NVO","NVOH","THNR","LU0154236417.USD","LU1093756168.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118199","title":"诺和诺德:从“销往中国”到“造福全球”","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118199","media":"经济日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650118199?lang=zh_cn&edition=full","pubTime":"2026-07-09 06:06","pubTimestamp":1783548409,"startTime":"0","endTime":"0","summary":"前不久,总部位于丹麦的全球性生物制药公司诺和诺德宣布,“中国同创”项目全球同步研发的首个基础胰岛素周制剂产品在中国上市;其位于天津的战略生产基地追加投资2亿元人民币,用于提升相关生产能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607093798863797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["OZEM","BK4585","BK4588","THNR","BK4532","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4007","PPH","IE00BKVL7J92.USD","NVOH","BK4599","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999426","title":"诺和诺德CEO:将推进中国业务和全球战略深度整合","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649999426?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:34","pubTimestamp":1783517673,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","NVOX","BK4588","NVO","PPH","IE00BKVL7J92.USD","BK4599","BK4532","NVOH","LU1093756325.SGD","BK4007","OZEM","LU0154236417.USD","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649441963","title":"Vivani Medical 与 Novo Nordisk 达成协议,评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139","url":"https://stock-news.laohu8.com/highlight/detail?id=2649441963","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649441963?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:12","pubTimestamp":1783480320,"startTime":"0","endTime":"0","summary":"Novo Nordisk 将对 Vivani 制备的司美格鲁肽植入剂进行非独家内部评估加利福尼亚州阿拉米达, July 08, 2026 -- Vivani Medical, Inc. 是一家开发新型超长效药物植入剂的创新型生物制药公司,今日宣布与 Novo Nordisk 签署一项新协议,授权 Novo Nordisk 评估旗下司美格鲁肽药物植入剂 NPM-139。依托 Vivani 的 NanoPortal 平台技术,正在开发 NPM-139 用于长期体重管理。此外,Vivani 预计将于 2026 年中期启动一项评估 NPM-139 司美格鲁肽植入剂的随机首次人体 1 期临床研究,并以 Wegovy 注射剂作为活性对照。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3323795/0/zh-hans/Vivani-Medical-%E4%B8%8E-Novo-Nordisk-%E8%BE%BE%E6%88%90%E5%8D%8F%E8%AE%AE-%E8%AF%84%E4%BC%B0%E7%94%A8%E4%BA%8E%E9%95%BF%E6%9C%9F%E4%BD%93%E9%87%8D%E7%AE%A1%E7%90%86%E7%9A%84%E5%BE%AE%E5%9E%8B%E8%B6%85%E9%95%BF%E6%95%88%E5%8F%B8%E7%BE%8E%E6%A0%BC%E9%B2%81%E8%82%BD%E6%A4%8D%E5%85%A5%E5%89%82-NPM-139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4007","THNR","VANI","BK4585","NVOH","IE00BKVL7J92.USD","BK4082","IE00BZ1G4Q59.USD","PPH","NVO","LU1093756168.USD","LU0154236417.USD","NVOX","BK4599","BK4588","LU1093756325.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159320796","title":"异动解读|诺和诺德盘中下跌3.05%,报48.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159320796","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159320796?lang=zh_cn&edition=full","pubTime":"2026-07-06 21:49","pubTimestamp":1783345799,"startTime":"0","endTime":"0","summary":"7月6日,诺和诺德盘中下跌3.05%,报48.70美元/股,成交额8019.73万美元。诺和诺德所在的制药行业中,整体表现疲弱,个股中,礼来跌2.0%,强生跌2.45%,辉瑞跌2.24%,默沙东跌1.94%,阿斯利康跌4.11%。Novo Nordisk A/S是一家全球性医疗保健公司,也是肥胖和糖尿病护理领域的世界领先企业,总部位于丹麦,业务遍及约80个国家,产品销往约170个国家。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649643191","title":"汇丰将诺和诺德目标价从280丹麦克朗上调至300丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649643191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649643191?lang=zh_cn&edition=full","pubTime":"2026-07-06 13:19","pubTimestamp":1783315176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0496365809.HKD","BK4007","BK4532","LU1093756325.SGD","00005","LU0128525689.USD","LU1093756168.USD","NVO","THNR","BK4599","LU2236285917.USD","IE00BZ1G4Q59.USD","NVOH","PPH","LU1267930227.SGD","LU0976567544.SGD","NVOX","LU0211326755.USD","OZEM","HSBC","BK4207","LU0211326839.USD","LU0052756011.USD","BK4521","HSBH","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","LU0310800965.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648685208","title":"诺和诺德(NVO)涨3.8% 施压供应商争取折扣 削减成本反攻减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648685208?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:24","pubTimestamp":1783002296,"startTime":"0","endTime":"0","summary":"消息面上,丹麦药企诺和诺德发函合作供应商,协商压低采购成本,意图扭转减肥药市场竞争劣势,抢夺礼来 占据的行业龙头地位。诺和诺德表示供应商参与让利并非强制要求,但让利成效将纳入后续合作评估维度。降本举措并非单一动作,今年 9 月诺和诺德推出大规模裁员计划,拟全球裁减 9000 名员工,叠加本次供应链压价,共同组成新任 CEO 主导的全面降本方案,依托压缩开支优化产品定价,争夺减肥药赛道市场份额。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NTE3MzYyMzA2NDI2MjU=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NTE3MzYyMzA2NDI2MjU=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302165","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","SG9999013999.USD","LU2237443465.HKD","SG9999014880.SGD","LU1983299246.USD","LU1267930730.SGD","IE00BJJMRZ35.SGD","LU1720051017.SGD","LU0345770993.USD","SG9999015945.SGD","LU1280957306.USD","IE00BJLML261.HKD","LU2089284900.SGD","BK4007","LU1291159041.SGD","LU0234572021.USD","LU2602419157.SGD","LU0316494557.USD","LU2361044865.SGD","LU1064131342.USD","LU0320765992.SGD","LU0823434740.USD","LU0256863811.USD","LU2746668974.SGD","LU2168564222.USD","LU0158827781.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0354030511.USD","LU0354030438.USD","LU1868836914.USD","LU2491049909.HKD","NVOH","SG9999001176.USD","IE00BKDWB100.SGD","LU2746668461.USD","LU2756315664.SGD","LU2471134952.CNY","LU0133085943.USD","SGXZ81514606.USD","LU1551013342.USD","LU1069344957.HKD","SG9999014906.USD","IE00B4R5TH58.HKD","LU0203202063.USD","LU2168564149.EUR","LU1868836591.USD","GB00BDT5M118.USD","LU2471134796.USD","BK4534","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU2461242641.AUD","LU1035775433.USD","LU0320765059.SGD","IE00BK4W5L77.USD","LU0323591593.USD","LU2417539215.USD","LU0689472784.USD","LU0058720904.USD","LU2357305700.SGD","LU0456855351.SGD","LU2237443622.USD","LU0154236417.USD","LU0417517546.SGD","LU0210536198.USD","LU0640476718.USD","LU2111349929.HKD","SGXZ99366536.SGD","NVOX","LU1988902786.USD","IE00B1XK9C88.USD","LU2087625088.SGD","LU2089984988.USD","LU2552382215.SGD","LU2023250504.SGD","SG9999014914.USD","IE00B775H168.HKD","LU2237438978.USD","LU2236285917.USD","BK4588","LU0385154629.USD","IE00B1BXHZ80.USD","BK4581","LU0353189763.USD","LU2213496289.HKD","LU0158827948.USD","SG9999018857.SGD","LU0256863902.USD","LU1061106388.HKD","LU0289739699.SGD","LU0889565916.HKD","SG9999018865.SGD","SG9999015978.USD","LU0943347566.SGD","LU2324357040.USD","LU0094547139.USD","LU1629891620.HKD","LU2237443382.USD","LU2361045086.USD","IE0004445239.USD","SG9999015986.USD","LU0683600562.USD","LU0882574139.USD","LU0672654240.SGD","LLII","LLYZ","LU1623119135.USD","IE00BJJMRY28.SGD","LU1868837136.USD","LU2361044949.HKD","SG9999015952.SGD","LU0122379950.USD","LU0820561909.HKD","LU2456880835.USD","LLYX","LU2023251221.USD","LU1145028129.USD","LU0432979614.USD","LU1804176565.USD","LU2471134879.HKD","IE00B2B36J28.USD","LU2237443549.SGD","LU2265009873.SGD","IE0001KFT4U8.USD","LU0820562030.AUD","BK4533","LU0203201768.USD","LU1023059063.AUD","LU2750360997.AUD","IE00BZ1G4Q59.USD","LU2896262040.SGD","IE0002141913.USD","IE0004445015.USD","ELIL","LLY","LU1712237335.SGD","LU0225283273.USD","LU0708995401.HKD","LU0238689110.USD","NVO","BK4585","IE00B7KXQ091.USD","LU2552382132.HKD","LU0466842654.USD","LU0114720955.EUR","LU1917777945.USD","LU2237443895.HKD","IE00BN29S564.USD","LU0061475181.USD","IE0009355771.USD","LU1974910355.USD","LU2491050071.SGD","IE00B4JS1V06.HKD","LU2360106947.USD","LU1232071149.USD","LU2108987350.USD","LU0109391861.USD","LU1127390331.HKD","LU2106854487.HKD","BK4599","LU0079474960.USD","LU2552382058.USD","LU1323610961.USD","LU2168564495.EUR","LU2063271972.USD","SGXZ31699556.SGD","LU2112291526.USD","LU0471298694.HKD","IE00BKPKM429.USD","LU1868836757.USD","SG9999017495.SGD","LU0786609619.USD","LU1989771016.USD","IE00BWXC8680.SGD","LU2264538146.SGD","LU0471298777.SGD","SG9999001176.SGD","LU2168564065.EUR","LU2089283258.USD","LU2168563687.JPY","SGXZ51526630.SGD","LU2237443978.SGD","LU2756315318.SGD","LU0198837287.USD","LU0006306889.USD","LU2028103732.USD","LU2462157665.USD","LU1551013425.SGD","IE00BJJMRX11.SGD","LU0097036916.USD","LU0266013472.USD","LU1868837300.USD","BK4516","ELIS","IE00BFTCPJ56.SGD","LU0096364046.USD","LU2471134523.USD","LU2491050154.USD","LU0109394709.USD","LU1093756325.SGD","LU0787776722.HKD","LU0882574055.USD","LU0820561818.USD","LU0106261372.USD","IE00BKVL7J92.USD","LU0964807845.USD","LU2023250330.USD","SGXZ57979304.SGD","LU2468319806.SGD","LU1548497426.USD","BK4532","LU2750360641.GBP","LU0353189680.USD","SG9999014898.SGD","LU1814569148.SGD","LU1093756168.USD","LU2271345857.HKD","LU1057294990.SGD","IE00BK4W5M84.HKD","LU1720051108.HKD","LU1366192091.USD","LU0823434583.USD","IE0005OL40V9.USD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176916059","title":"异动解读|诺和诺德盘中上涨3.09%,Medicare覆盖落地叠加供应链降本举措提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1176916059","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176916059?lang=zh_cn&edition=full","pubTime":"2026-07-02 21:55","pubTimestamp":1783000532,"startTime":"0","endTime":"0","summary":"7月2日,诺和诺德盘中上涨3.09%,报50.355美元/股,成交额1.11亿美元。消息面上,美国联邦医疗保险自7月1日起首次将GLP-1类减肥药纳入常规报销体系,符合条件的Medicare参保患者可按月自付50美元购得Wegovy,政策利好持续发酵。同日,有报道称诺和诺德正寻求供应商降低原材料价格以维持市场竞争力,显示公司在需求放量的同时积极优化成本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176561117","title":"异动解读|诺和诺德盘中上涨3.18%,美国联邦医保首次覆盖减肥药利好兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=1176561117","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176561117?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:34","pubTimestamp":1782916499,"startTime":"0","endTime":"0","summary":"7月1日,诺和诺德盘中上涨3.18%,报49.32美元/股,成交额1.6亿美元。消息面上,美国联邦医疗保险自7月1日起首次将GLP-1类减肥药物纳入常规报销体系,诺和诺德同日宣布符合条件的Medicare参保患者现可按月自付50美元购得Wegovy。值得注意的是,诺和诺德逆势走强,同行业礼来跌1.33%、阿斯利康跌2.93%、默沙东跌1.84%,板块整体承压下公司凭借政策直接利好独立走高。此前杰富瑞及高盛亦相继上调诺和诺德目标价,反映市场对其GLP-1商业化前景持续看好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648651733","title":"诺和诺德:符合条件的联邦医疗保险参保患者现在可按月自付50美元购得Wegovy。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648651733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648651733?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:01","pubTimestamp":1782903695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU1093756325.SGD","BK4585","IE00BZ1G4Q59.USD","NVOX","BK4007","BK4599","LU1093756168.USD","NVO","LU0154236417.USD","NVOH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555250","title":"美国联邦医疗保险七月起首次覆盖减肥药物,诺和诺德股价应声上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555250","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647555250?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:27","pubTimestamp":1782822420,"startTime":"0","endTime":"0","summary":"美国联邦医疗保险周一宣布,自7月1日起将首次覆盖选择性GLP-1类减肥药物,包括诺和诺德生产的司美格鲁肽注射剂。这意味着数千万Medicare参保人将有机会获得这类广受欢迎的减肥药物的报销资格。受此消息提振,诺和诺德股价在周一交易中上涨约0.6%。 根据美国医疗保险与医疗补助服务中心发布的最终指南,此次覆盖适用于被诊断为肥胖症的患者,即体重指数达到30或以上的人群。此次政策调整是Medicare成立以来首次将减肥药物纳入常规报销体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-30/doc-inifexfq1520001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0106831901.USD","LU2271345857.HKD","LU0912757837.SGD","LU1074936037.SGD","NVOH","LU0267386448.USD","LU0225283273.USD","LU2357305700.SGD","LU0971096721.USD","LU0210528500.USD","LU0390134368.USD","LU0053666078.USD","BK4588","LU1989772840.SGD","LU2264538146.SGD","LU1244550494.USD","LU2487616109.SGD","NVO","LU1064131342.USD","LU1732799900.SGD","LU0795875169.SGD","BK4504","LU0557290698.USD","BK4532","BK4599","LU1244550221.USD","BK4127","LU1791710582.SGD","BK4516","LU1988902786.USD","LU2133065610.SGD","NVOX","LU1093756325.SGD","LU0006306889.USD","LU1363072403.SGD","LU0320765646.SGD","LU0154236417.USD","LU1668664300.SGD","LU1732800096.USD","BK4007","LU0795875086.SGD","LU0234570918.USD","LU0314104364.USD","LU2347655156.SGD","BK4534","MS","LU1989772923.USD","IE00BZ1G4Q59.USD","LU1791710400.SGD","BK4581","LU2023251221.USD","LU1162221912.USD","LU2028103732.USD","LU0882574139.USD","LU1244550577.SGD","LU2089284900.SGD","IE00BKVL7J92.USD","LU1720051108.HKD","LU1720051017.SGD","LU1093756168.USD","LU0106261372.USD","BK4585","LU0098860793.USD","LU2111349929.HKD","LU0158827781.USD","LU1548497426.USD","LU0528227936.USD","LU2089283258.USD","LU0158827948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647581242","title":"杰富瑞将诺和诺德目标股价从270丹麦克朗上调至285丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581242","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647581242?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:03","pubTimestamp":1782792190,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","BK4532","NVOH","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","NVO","NVOX","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646033697","title":"高盛将诺和诺德目标价从305丹麦克朗上调至310丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646033697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646033697?lang=zh_cn&edition=full","pubTime":"2026-06-26 13:03","pubTimestamp":1782450188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4599","IE00BKVL7J92.USD","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOX","BK4007","NVOH","BK4532","LU1093756325.SGD","BK4585","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646756628","title":"诺和诺德(NVO.US)美国负责人表示Wegovy口服剂型销量中直接面向消费者的销售占比达90%注射剂型该比例为30%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646756628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646756628?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:03","pubTimestamp":1782378219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","LU0154236417.USD","NVOX","BK4007","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","BK4588","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":0.0342},{"period":"1month","weight":0.1512},{"period":"3month","weight":0.2353},{"period":"6month","weight":-0.1888},{"period":"1year","weight":-0.2478},{"period":"ytd","weight":-0.0063}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0},{"period":"3month","weight":0.0757},{"period":"6month","weight":0.0913},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司,也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦,业务遍及约80个国家,产品销往约170个国家。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.120105},{"month":2,"riseRate":0.6,"avgChangeRate":0.019219},{"month":3,"riseRate":0.444444,"avgChangeRate":0.006415},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018023},{"month":5,"riseRate":0.565217,"avgChangeRate":0.019713},{"month":6,"riseRate":0.695652,"avgChangeRate":0.026728},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000467},{"month":8,"riseRate":0.533333,"avgChangeRate":0.006145},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002979},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}